12:00 AM
Dec 03, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Aubagio teriflunomide regulatory update

Australia's Therapeutic Goods Administration ( TGA) approved once-daily, oral Aubagio teriflunomide from Sanofi to treat relapsing...

Read the full 64 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >